QualityStocksNewsBreaks Archives - Page 371 of 1387

WednesdayJul 13, 2022 2:37 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Nearing Start Date for Its Human Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the pending start of its upcoming human nicotine study NIC-H22-1. Through the study, Lexaria expects to evidence that processing purified nicotine with its patented drug delivery technology, DehydraTECH(TM), leads to enhanced oral-tissue absorption and reduced negative experiences. NIC-H22-1, a minimum 36-person human pharmacokinetic (“PK”) randomized, double blinded, cross-over study, will compare Lexaria’s DehydraTECH-nicotine pouch performance to that of existing leading brands currently sold in the U.S. such as ON! and Zyn. The primary objective of the study is data collection from blood samples that will evidence…

WednesdayJul 13, 2022 2:20 pm

QualityStocksNewsBreaks – Standard Lithium Ltd (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L) Releases Update on Key Developments

Standard Lithium (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L), an innovative technology and lithium project-development company, is reporting on recent corporate and project developments. Highlights of the update include additions to SLI management, a master service agreement (“MSA”) with Telescope Innovations (“TELI”), the progress of a DFS/FEED study award and increased shareholdings by senior management. Specifically, SLI named new positions and members to its management team, including Jason Tielker as vice president of project delivery and Angus Remfry as director of project delivery. In addition, the company is reviewing Pre-FEED deliverables related to its first commercial plant with the anticipation…

WednesdayJul 13, 2022 2:10 pm

QualityStocksNewsBreaks – Friendable Inc.’s (FDBL) 360 Offering Sees Revenue Increases, General Artist Interest to Its FeaturedX Branded Service

Friendable (OTC: FDBL), a mobile technology and marketing company, today announced its six-month history following its acquisition of Artist Republik and FeaturedX brands/offerings. Upon these acquisitions, management has been focused on both, starting with Artist Republik, and has now just completed a phase II upgrade of FeaturedX, which the company attributes as the main contributing factor to revenue increases and ultimately surpassing the $168,000 mark from the acquisition to date. “It’s been our mission to provide a full 360 offering for all independent music artists and our team is convinced we have just that, and much more, from music distribution,…

WednesdayJul 13, 2022 2:02 pm

QualityStocksNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) Completes Testing, Marks Milestone on Commercialization Path

Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F), a clean-technology company developing transformative power conversion technologies and control system solutions for next-generation EVs and electrical systems, announced that it has completed proof of concept testing designed to demonstrate the efficiencies of its 250kW 800V commercial prototype traction inverter. During the testing, the high-efficiency inverter showed reduction in switching losses of +90% compared to conventional, hard-switched inverters, which is a significant milestone for the company as it works toward commercialization. According to the announcement, a comparison of losses between soft-switching and hard-switching was calculated with Hillcrest’s system tested with 470V…

TuesdayJul 12, 2022 4:43 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (SILO) Announces Positive Results of New Study

Silo Pharma (OTCQB: SILO), a development-stage biopharmaceutical company, today announced that its novel liposomes reached a positive endpoint in animal studies showing effectiveness and reduced toxicity using a subcutaneous delivery method. “The successful results of our study show that the subcutaneous route of liposomal administration is well-suited for use in targeted drug delivery of anti-arthritic agents. We suggest that this drug delivery approach would not only enhance efficacy but also reduce systemic toxicity,” said Eric Weisblum, CEO of Silo Pharma. “In our previous work, ART-1-Cy7-liposomes injected i.v. demonstrated homing to arthritic joints and four hours was an optimal time point…

TuesdayJul 12, 2022 3:21 pm

QualityStocksNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) CYB003 Phase 1/2a Clinical Trial Through Clinilabs Begins Enrollment

Clinilabs Drug Development Corporation, a global, full-service contract research organization with deep expertise in central nervous system drug development, today announced commencement of enrollment in a phase 1/2a clinical trial of CYB003. Being developed by Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” CYB003 is the first novel psilocybin analog to be evaluated in phase 1/2a development for the treatment of major depressive disorder (“MDD”). “Clinilabs is honored to be working with Cybin, an innovator in the development of novel psychedelic therapeutics, to conduct its first-in-human clinical trial of CYB003,” said…

TuesdayJul 12, 2022 2:52 pm

QualityStocksNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) (FRA: 6BC0) Announces Promotion of Patrick Dunn to CFO, Director

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) (FRA: 6BC0), a publicly-traded investment company, today announced it has promoted its Vice President, Finance Patrick Dunn to CFO and has appointed him as a member of the company’s board of directors. Dunn, CPA, a founding partner of Dunn, Pariser & Peyrot, is an experienced senior executive with a proven track record of investing in and building highly successful agribusinesses throughout North America. “We are proud to promote Patrick Dunn to CFO of Eat Well Group and to have him join the board of directors of the company. His first-hand experience in…

TuesdayJul 12, 2022 2:45 pm

QualityStocksNewsBreaks – Home Bistro Inc. (HBIS) Announces New Pricing Plan Following Successful Beta Test

Home Bistro (OTC: HBIS), a leading online meal-delivery platform that offers celebrity chef-inspired, gourmet and lifestyle ready-made meals, is planning on rolling out a new three-tiered pricing plan, effective Aug. 1, 2022. The announcement comes after the company saw positive results from beta testing of the enhanced meal-pricing structure. “Over the past six months, we have spent considerable time studying ways to reduce our product costs while expanding our top line revenue and increasing gross profit margin,” said Home Bistro CEO Zalmi Duchman in the press release. “By analyzing the current market and closely studying the value proposition of alternative…

TuesdayJul 12, 2022 2:20 pm

QualityStocksNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Upgrades EDI to Include Location Sharing, Shipment Status Improvements

Freight Technologies (NASDAQ: FRGT), a technology company developing solutions to optimize and automate the supply chain process and providing a platform for B2B cross-border shipping in the NAFTA region, announced that it has upgraded its electronic data interchange (“EDI”). The upgraded EDI now features the ability to enable location sharing and shipment status changes. “To help increase Fr8App large shippers’ efficiency and the stickiness of our application, we continue to improve our EDI, which increases notification speed and reduces costs with our agile, paperless electronic exchange of data,” said Fr8Tech and Fr8App CEO Javier Selgas in the press release. “Recently,…

TuesdayJul 12, 2022 10:00 am

QualityStocksNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Milestone Agreement with DPL Featured in NGT News Article

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, recently signed a binding agreement with DelPack Logistics LLC (“DPL”), an Amazon delivery service partner, for DPL to purchase up to 600 Mullen Class 2 EV cargo vans over a period of 18 months. The vans will be fully homologated for the United States, of which the first 300 can be delivered by Nov. 30, 2022, at the request of DPL. “This agreement is a milestone for Mullen Automotive,” David Michery, CEO and chairman of MULN was quoted as saying in an article published by NGT News. “DelPack is a…

Site Search

Company Search

Category: QualityStocksNewsBreaks